Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iovance Biotherapeutics Inc (IOVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iovance Biotherapeutics Inc 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 USA

P: 650-260-7120

Description:

Iovance Biotherapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Iovance Biotherapeutics Inc., formerly known as Lion Biotechnologies Inc., is based in SAN CARLOS, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,711,132
Shares Outstanding, K 123,514
Annual Sales, $ 0 K
Annual Net Income, $ -123,580 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -36,950 K
60-Month Beta 1.39
% of Insider Shareholders 9.90%
% of Institutional Shareholders 94.96%
Float, K 111,286
% Float 90.10%

Growth:

1-Year Return 67.16%
3-Year Return 184.99%
5-Year Return 255.56%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/05/19
Earnings Per Share ttm -1.27
EPS Growth vs. Prev Qtr -11.11%
EPS Growth vs. Prev Year 3.23%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-100 on 09/27/13

IOVA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -8.97
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -37.60
Return-on-Assets (Before Tax) -35.79
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.51
Book Value/Share 3.52
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar